MedMen on Its Last Legs with Disappointing Q2 Results

Scott Willis·February 26, 2020

MedMen (CNSX: MMEN) is cutting costs, but is it enough to stave off bankruptcy now, or in two...

Valens Reports Solid Q4 Results Driven by White Label Business

Scott Willis·February 24, 2020

Valens continues to set itself apart with excellent execution, but will industry headwinds drag even this high flyer...

Andy Zhou·February 22, 2020

A weekly review of only the most important news to impact your marijuana stocks portfolio....

Andy Zhou·February 15, 2020

A weekly review of only the most important cannabis news to impact your portfolio...

Andy Zhou·February 14, 2020

Revenue was $1.813M which missed analysts' estimates of $2.4M. EPS was -$0.01 which was in-line analysts' estimates of...

Scott Willis·February 14, 2020

Is Canopy on the mend with Q3 2020 earnings or is more pain to come for the Canadian...

Andy Zhou·February 8, 2020

A weekly review of only the most important cannabis news to impact your portfolio...

Scott Willis·February 6, 2020

With the two architects of its troubles gone, is Aurora Cannabis (TSE: ACB; NYSE: ACB) poised for a...

Andy Zhou·February 1, 2020

We cover only the news that directly impacts your marijuana stocks portfolio. All the rest is just noise....

Username
Password

	Remember Me Lost your password?